Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M605Revenue (TTM) $M92.8Net Margin (%)-193.5Altman Z-Score-9.5
Enterprise Value $M738EPS (TTM) $-1.5Operating Margin %-151.9Piotroski F-Score3
P/E(ttm)--Beneish M-Score7.4Pre-tax Margin (%)-194.0Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio1.2Cash flow > EarningsY
Price/Sales6.05-y EBITDA Growth Rate %-32.0Current Ratio1.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-114.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M129ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with MACK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MACKJoel Greenblatt 2015-06-30 Sold Out $10.76 - $13.67
($12.09)
$ 4.68-61%Sold Out0
MACKJoel Greenblatt 2015-03-31 Buy $8.78 - $12.48
($10.82)
$ 4.68-57%New holding13,433
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MACK is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


MACK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Schoeberl Birgit M.Head of Discovery 2016-07-25Sell50,000$5.5-13.64view
PORTER MICHAEL EDirector 2016-03-17Buy5,000$7.2-34.03view
PORTER MICHAEL EDirector 2016-03-15Buy5,000$7.65-37.91view
PORTER MICHAEL EDirector 2016-03-08Buy10,000$7.09-33view
PORTER MICHAEL EDirector 2016-03-03Buy15,000$6.39-25.67view
PORTER MICHAEL EDirector 2016-03-01Buy20,000$6.11-22.26view
Lee Vivian SDirector 2016-02-29Buy35,000$5.5-13.64view
McClements William M.Head of Corporate Operations 2016-02-29Buy2,000$5.72-16.96view
Stewart Edward J.Head of Commercial 2016-01-05Sell4,000$8-40.63view
Stewart Edward J.Head of Commercial 2015-12-01Sell5,000$9.33-49.09view

Quarterly/Annual Reports about MACK:

    News about MACK:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Starbucks Corp, KD Supply Holdings Inc, Capital One Financial Corp, Merr Dec 14 2014 

    More From Other Websites
    Noble Corp., Express Stay in 52-Week Low Club Again Friday Aug 26 2016
    Express, Noble Corp. Lead Thursday’s 52-Week Low Club Aug 25 2016
    7 Stocks Under $10 Making Big Up Moves Aug 24 2016
    ETF’s with exposure to Merrimack Pharmaceuticals, Inc. : August 22, 2016 Aug 22 2016
    MERRIMACK PHARMACEUTICALS INC Financials Aug 12 2016
    Merrimack Pharmaceuticals, Inc. :MACK-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10,... Aug 10 2016
    ETF’s with exposure to Merrimack Pharmaceuticals, Inc. : August 9, 2016 Aug 09 2016
    Merrimack Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : MACK-US :... Aug 08 2016
    Edited Transcript of MACK earnings conference call or presentation 4-Aug-16 8:30pm GMT Aug 05 2016
    Merrimack (MACK) Q2 Loss Wider than Expected, Sales Top Aug 05 2016
    Merrimack reports 2Q loss Aug 04 2016
    Merrimack reports 2Q loss Aug 04 2016
    Merrimack Reports Second Quarter 2016 Financial Results Aug 04 2016
    MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 04 2016
    Merrimack Reports Second Quarter 2016 Financial Results Aug 04 2016
    Q2 2016 Merrimack Pharmaceuticals Inc Earnings Release - After Market Close Aug 04 2016
    Merrimack (MACK): Can the Stock Surprise in Q2 Earnings? Aug 01 2016
    ETF’s with exposure to Merrimack Pharmaceuticals, Inc. : July 29, 2016 Jul 29 2016
    Merrimack Announces ONIVYDE® Regimen Receives Positive CHMP Opinion in European Union Jul 25 2016
    Merrimack Announces ONIVYDE® Regimen Receives Positive CHMP Opinion in European Union Jul 25 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)